ACM
BSX.PRA
Advent Capital Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Hold |
0
| – | -$4.81M | – | 246 |
|
|
2023
Q1 | – | Hold |
0
| – | -$11.5M | – | 140 |
|
|
2022
Q4 | – | Sell |
-233,351
| Closed | -$23.9M | – | 126 |
|
|
2022
Q3 | $23.9M | Sell |
233,351
-43,269
| -16% | -$4.44M | 0.43% | 83 |
|
|
2022
Q2 | $28.2M | Buy |
276,620
+27,423
| +11% | +$2.79M | 0.5% | 76 |
|
|
2022
Q1 | $29.1M | Sell |
249,197
-89,680
| -26% | -$10.5M | 0.47% | 74 |
|
|
2021
Q4 | $38.8M | Buy |
+338,877
| New | +$38.8M | 0.65% | 54 |
|
|
2020
Q4 | – | Sell |
-265,263
| Closed | -$29.5M | – | 212 |
|
|
2020
Q3 | $29.5M | Buy |
265,263
+85,063
| +47% | +$9.46M | 0.65% | 61 |
|
|
2020
Q2 | $18.9M | Buy |
+180,200
| New | +$18.9M | 0.44% | 72 |
|